BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23040692)

  • 1. Bordetella holmesii endocarditis in a patient with systemic lupus erythematous treated with immunosuppressive agents.
    Bassetti M; Nicco E; Giacobbe DR; Marchese A; Coppo E; Barbieri R; Viscoli C
    J Chemother; 2012 Aug; 24(4):240-2. PubMed ID: 23040692
    [No Abstract]   [Full Text] [Related]  

  • 2. Bordetella holmesii endocarditis: case report and review of literature.
    Couturier AP; Dahl K
    Pediatr Infect Dis J; 2014 Jun; 33(6):661-4. PubMed ID: 24463808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bordetella holmesii bacteremia in a renal transplant recipient: emergence of a new pathogen.
    Chambaraud T; Dickson Z; Ensergueix G; Barraud O; Essig M; Lacour C; Allard J; Bocquentin F; Aldigier JC; Rerolle JP
    Transpl Infect Dis; 2012 Dec; 14(6):E134-6. PubMed ID: 22998023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cutaneous involvement in systemic Chagas disease in immunocompromised patient].
    Canese A; Di Martino Ortiz B; González Burgos L; Centurión MÉ
    Med Clin (Barc); 2012 May; 138(14):e27. PubMed ID: 22093407
    [No Abstract]   [Full Text] [Related]  

  • 5. Progressive multifocal leukoencephalopathy in a minimally immunosuppressed patient with systemic lupus erythematosus treated with dapsone.
    Stahl NI
    J Rheumatol; 2008 Apr; 35(4):725-7. PubMed ID: 18398953
    [No Abstract]   [Full Text] [Related]  

  • 6. [Strongyloides stercoralis hyperinfection syndrome in a Colombian patient receiving immunosuppressive treatment].
    Rojo-Marcos G; Cuadros-González J; González-Juárez MJ; Gómez-Ayerbe C
    Enferm Infecc Microbiol Clin; 2009; 27(7):432-4. PubMed ID: 19477050
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytomegalovirus-induced Colon Perforation in Systemic Lupus Erythematosus.
    Glushko T; Marcus VA; Colmegna I
    J Rheumatol; 2016 Feb; 43(2):459-60. PubMed ID: 26834256
    [No Abstract]   [Full Text] [Related]  

  • 8. Bordetella holmesii meningitis in an asplenic patient with systemic lupus erythematosus.
    Livovsky DM; Leibowitz D; Hidalgo-Grass C; Temper V; Salameh S; Korem M
    J Med Microbiol; 2012 Aug; 61(Pt 8):1165-1167. PubMed ID: 22556329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kaposi Sarcoma complicating systemic lupus erythematosus treated with immunosuppression.
    Klein MB; Pereira FA; Kantor I
    Arch Dermatol; 1974 Oct; 110(4):602-4. PubMed ID: 4414026
    [No Abstract]   [Full Text] [Related]  

  • 10. [Systemic lupus erythematosus. Etiopathogenesis and immunosuppressive therapy].
    Clément F
    Schweiz Med Wochenschr; 1973 Oct; 103(40):1369-77. PubMed ID: 4755631
    [No Abstract]   [Full Text] [Related]  

  • 11. Prosthetic valve endocarditis caused by Bordetella holmesii, an Acinetobacter lookalike.
    Jonckheere S; De Baere T; Schroeyers P; Soetens O; De Bel A; Surmont I
    J Med Microbiol; 2012 Jun; 61(Pt 6):874-877. PubMed ID: 22403142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bordetella hinzii: An Unexpected Pathogen in Native Valve Endocarditis.
    Zohourian H; Sorokin AV; Ladna JM; Mushtaq F
    Can J Cardiol; 2019 Nov; 35(11):1604.e17-1604.e19. PubMed ID: 31679629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infective endocarditis caused by Erysipelothrix rhusiopathiae in a patient with systemic lupus erythematosus.
    Thomas N; Jesudason M; Mukundan U; John TJ; Seshadri MS; Cherian AM
    J Assoc Physicians India; 1996 Mar; 44(3):223. PubMed ID: 9251330
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of malignant cerebral lymphoma in a patient with systemic lupus erythematosus treated with immunosuppression.
    Lipsmeyer EA
    Arthritis Rheum; 1972; 15(2):183-6. PubMed ID: 4554891
    [No Abstract]   [Full Text] [Related]  

  • 15. Bordetella holmesii: a rare cause of bacterial endocarditis in a post-splenectomy patient.
    Clare S; Ahmed T; Singh R; Gough S
    BMJ Case Rep; 2010 May; 2010():. PubMed ID: 22736732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Case of systemic erythematodes on long-term care with repeated development of severe cytomegalovirus infection].
    Masago R; Fukuma H
    Nihon Naika Gakkai Zasshi; 1998 Aug; 87(8):1555-6. PubMed ID: 9780684
    [No Abstract]   [Full Text] [Related]  

  • 17. Bordetella holmesii bacteremia: a newly recognized clinical entity among asplenic patients.
    Shepard CW; Daneshvar MI; Kaiser RM; Ashford DA; Lonsway D; Patel JB; Morey RE; Jordan JG; Weyant RS; Fischer M
    Clin Infect Dis; 2004 Mar; 38(6):799-804. PubMed ID: 14999621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute nonlymphocytic leukemia after treatment of systemic lupus erythematosus with immunosuppressive agents.
    Vasquez S; Kavanaugh AF; Schneider NR; Wacholtz MC; Lipsky PE
    J Rheumatol; 1992 Oct; 19(10):1625-7. PubMed ID: 1464880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combined immunosuppressive treatment of systemic lupus erythematosus].
    Pluzańska A; Dmochowska M; Orlowski Z; Pawlowski J; Krauze-Jaworska H; Krykowski E; Zebrowski A
    Pol Arch Med Wewn; 1974 Sep; 52(3):275-81. PubMed ID: 4418141
    [No Abstract]   [Full Text] [Related]  

  • 20. Rituximab treatment in a child with rosai-dorfman disease and systemic lupus erythematosus.
    Alqanatish JT; Houghton K; Bond M; Senger C; Tucker LB
    J Rheumatol; 2010 Aug; 37(8):1783-4. PubMed ID: 20675857
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.